Business Description
Cosmos Health Inc
NAICS : 423460
SIC : 5122
ISIN : US2214133058
Compare
Compare
Traded in other countries / regions
COSM.USAV67A.Germany IPO Date
2023-09-20Description
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.3 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.32 | |||||
| Debt-to-EBITDA | -0.6 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -1.82 | |||||
| Beneish M-Score | -4 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -65 | |||||
| 3-Year EPS without NRI Growth Rate | -254.3 | |||||
| 3-Year FCF Growth Rate | 54.4 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.72 | |||||
| 9-Day RSI | 48.9 | |||||
| 14-Day RSI | 49.43 | |||||
| 3-1 Month Momentum % | -24.26 | |||||
| 6-1 Month Momentum % | 16.09 | |||||
| 12-1 Month Momentum % | -30.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.44 | |||||
| Quick Ratio | 1.24 | |||||
| Cash Ratio | 0.13 | |||||
| Days Inventory | 35.19 | |||||
| Days Sales Outstanding | 130.63 | |||||
| Days Payable | 82.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -212.1 | |||||
| Shareholder Yield % | -10.34 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 8.1 | |||||
| Operating Margin % | -35.98 | |||||
| Net Margin % | -36.39 | |||||
| FCF Margin % | -12.26 | |||||
| ROE % | -55.95 | |||||
| ROA % | -31.35 | |||||
| ROIC % | -39.95 | |||||
| 3-Year ROIIC % | -116.48 | |||||
| ROC (Joel Greenblatt) % | -64.79 | |||||
| ROCE % | -47.29 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 79.44 | |||||
| PS Ratio | 0.23 | |||||
| PB Ratio | 0.51 | |||||
| Price-to-Tangible-Book | 0.65 | |||||
| EV-to-EBIT | -1.32 | |||||
| EV-to-EBITDA | -1.4 | |||||
| EV-to-Revenue | 0.46 | |||||
| EV-to-Forward-Revenue | 0.37 | |||||
| EV-to-FCF | -3.75 | |||||
| Price-to-GF-Value | 1.59 | |||||
| Price-to-Median-PS-Value | 0.18 | |||||
| Price-to-Net-Current-Asset-Value | 2.59 | |||||
| Earnings Yield (Greenblatt) % | -75.76 | |||||
| FCF Yield % | -38.14 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cosmos Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 51.393 | ||
| EPS (TTM) (€) | -2.231 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 96.73 | ||
| 14-Day RSI | 49.43 | ||
| 14-Day ATR (€) | 0.031027 | ||
| 20-Day SMA (€) | 0.70695 | ||
| 12-1 Month Momentum % | -30.61 | ||
| 52-Week Range (€) | 0.4472 - 1.4 | ||
| Shares Outstanding (Mil) | 23.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cosmos Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cosmos Health Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cosmos Health Inc Frequently Asked Questions
What is Cosmos Health Inc(STU:V67A)'s stock price today?
The current price of STU:V67A is €0.70. The 52 week high of STU:V67A is €1.40 and 52 week low is €0.45.
When is next earnings date of Cosmos Health Inc(STU:V67A)?
The next earnings date of Cosmos Health Inc(STU:V67A) is 2025-02-14 Est..
Does Cosmos Health Inc(STU:V67A) pay dividends? If so, how much?
Cosmos Health Inc(STU:V67A) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers